Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research ...

Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure ...

NEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...

Since the announcements by federal health authorities earlier this year that federal mRNA vaccine funding will be curtailed, ...

Moderna will get $54M from a global coalition for a bird flu mRNA vaccine after the US canceled a $760M deal and cut mRNA ...

Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the ...

Moderna MRNA announced that the Coalition for Epidemic Preparedness Innovations (“CEPI”) will invest up to $54.3 million in ...

BioNTech SE ( ($BNTX) ) has provided an update. On December 18, 2025, BioNTech SE announced it had closed its acquisition of CureVac N.V., ...

No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells—an advance ...

SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.

Can the weakened immune systems of older individuals be rejuvenated? Researchers from the German Cancer Research Center (DKFZ ...